Albert Dickan, MD

home / authors / albert-dickan-md

Dr Dickan is a third-year psychiatry resident at Creighton University.

Articles

schizophrenia

Xanomeline-Trospium as a Novel Agent for Treatment of Psychosis in Schizophrenia

Caitlin Leconte, MD;Albert Dickan, MD;Haley Schuster, MD;Mark Mullen, MD;Rajesh R. Tampi, MD, MS, DFAPA, DFAAGP
February 17th 2025

Recent research demonstrated that xanomeline-trospium is more efficacious than placebo in treating positive and negative psychotic symptoms in adults with schizophrenia.

How efficacious is brexpiprazole as a treatment for agitation associated with Alzheimer disease?

Exploring the Role of Brexpiprazole in Alzheimer Dementia Agitation

Justin Allen, MD;Albert Dickan, MD;Jesse Woo, MD;Mark Mullen, MD;Rajesh R. Tampi, MD, MS, DFAPA, DFAAGP
January 16th 2024

How efficacious is brexpiprazole as a treatment for agitation associated with Alzheimer disease?

Latest Updated Articles

Mini Quiz: Treatment for Pedophilia?
Published: March 19th 2021 | Updated: April 1st 2025
Mini Quiz: Treatment for Pedophilia?
smoking
Published: March 27th 2025 | Updated: April 1st 2025
In Schizophrenia, Nicotine Enhances Cognitive Performance by Improving Brain Network Function
emotion cognition
Published: March 25th 2025 | Updated: April 1st 2025
Emotion and Cognitive Control: An Essential Partnership for Adaptive Behavior
sex differences
Published: March 26th 2025 | Updated: April 1st 2025
Are There Sex Differences in Cognition and Does It Matter?
cognition fog
Published: March 24th 2025 | Updated: April 1st 2025
When the Fog Doesn’t Lift: Targeting Cognitive Dysfunction in Depression
cognition
Published: March 21st 2025 | Updated: April 1st 2025
Cognition Is Like Art—You Know It When You See It
© 2025 MJH Life Sciences

All rights reserved.